EPHB4 and head and neck squamous cell carcinoma: Preclinical and clinical studies have investigated the use of EphB4-Human Serum Albumin Fusion Protein (sEphB4-HAS) in the treatment of cancer, particularly head and neck squamous cell carcinoma (HNSCC).